QIAGEN N.V. to Report Fourth Quarter and Full Year 2018 Results

VENLO, The Netherlands–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as
previously announced to release its report on results for the fourth
quarter 2018 on Monday, February 4 at approximately 22:05 Central
European Time (CET) / 16:05 Eastern Standard Time (EST). A
conference call is planned for Tuesday, February 5 at 15:00 CET /
9:00 EST hosted by Peer M. Schatz, Chief Executive Officer, and Roland
Sackers, Chief Financial Officer.

Conference Call and Webcast Details
The conference call will
begin at 15:00 CET / 9:00 EST on Tuesday February 5, 2019.

Interested parties may listen to the call by

+1 646 828 8195 (U.S.), +44 (0)330 336 9401 (UK),
+49 (0)69 2222 10763 (Germany).
To avoid waiting time, please join
the event conference 5-10 minutes prior to the start time using
the following Passcode: 966935

The webcast will be accessible at:

A conference call replay will be available by using the following link:

Contact: IR@qiagen.com


QIAGEN N.V., a Netherlands-based holding company, is the leading global
provider of Sample to Insight solutions that enable customers to gain
valuable molecular insights from samples containing the building blocks
of life. Our sample technologies isolate and process DNA, RNA and
proteins from blood, tissue and other materials. Assay technologies make
these biomolecules visible and ready for analysis. Bioinformatics
software and knowledge bases interpret data to report relevant,
actionable insights. Automation solutions tie these together in seamless
and cost-effective workflows. QIAGEN provides solutions to more than
500,000 customers around the world in Molecular Diagnostics (human
healthcare), Applied Testing (forensics, veterinary testing and food
safety), Pharma (pharma and biotech companies) and Academia (life
sciences research).

As of September 30, 2018, QIAGEN employed approximately 4,900 people in
over 35 locations worldwide.

Further information can be found at http://www.qiagen.com.


John Gilardi
Vice President Corporate Communications and Investor
+49 2103 29 11711
+1 240 686 2222
Email: ir@qiagen.com

Dr. Sarah Fakih
Director Investor Relations
+49 2103 29 11457

Thank you for donating to DutchNews.nl.

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation